The Journal of Immunology, Vol 149, Issue 4 1381-1387, Copyright © 1992 by American Association of Immunologists

ARTICLES

Expression of complement components of the alternative pathway by glioma cell lines

P Gasque, N Julen, AM Ischenko, C Picot, C Mauger, C Chauzy, J Ripoche and M Fontaine
European Institute for Peptide Research INSERM U-78, Bois-Guillaume, France.

Glioma cell lines express proteins of the complement alternative pathway, namely C3, factor B, factor H, and factor I. Secretion of these proteins was shown by a sensitive and specific ELISA. C3 and factor H were rapidly secreted by glioma cell line CB193 and reached a concentration of 140 ng/ml/10(6) cells after 72 h of culture. Factor B and factor I were secreted at a lower rate and reached concentrations of 25 and 15 ng/ml/10(6) cells, respectively. Western blot and immunoprecipitation experiments showed that secreted proteins were identical to the corresponding plasma proteins. For factor H, besides the well known 150-kDa species, an additional polypeptide of 45 kDa with factor H immunoreactivity was observed. This species corresponded to the N-terminal truncated form found in plasma. In preliminary experiments, we observed control of these syntheses by cytokines. IL-1 beta significantly increased C3 secretion, with no effect on factor H. Secretion of factor H was enhanced by IFN-gamma. These results show that a glioma cell line could be a useful tool to study complement biosynthesis by glial cells in humans.

This article has been cited by other articles:

				D. Ajona, Y.-F. Hsu, L. Corrales, L. M. Montuenga, and R. Pio Down-Regulation of Human Complement Factor H Sensitizes Non-Small Cell Lung Cancer Cells to Complement Attack and Reduces In Vivo Tumor Growth J. Immunol., May 1, 2007; 178(9): 5991 - 5998. [Abstract] [Full Text] [PDF]

				D. Ajona, Z. Castano, M. Garayoa, E. Zudaire, M. J. Pajares, A. Martinez, F. Cuttitta, L. M. Montuenga, and R. Pio Expression of Complement Factor H by Lung Cancer Cells: Effects on the Activation of the Alternative Pathway of Complement Cancer Res., September 1, 2004; 64(17): 6310 - 6318. [Abstract] [Full Text] [PDF]

				M. Kuraya, M. Matsushita, Y. Endo, S. Thiel, and T. Fujita Expression of H-ficolin/Hakata antigen, mannose-binding lectin-associated serine protease (MASP)-1 and MASP-3 by human glioma cell line T98G Int. Immunol., January 1, 2003; 15(1): 109 - 117. [Abstract] [Full Text] [PDF]

				G. T. Tran, S. J. Hodgkinson, N. Carter, M. Killingsworth, S. T. Spicer, and B. M. Hall Attenuation of Experimental Allergic Encephalomyelitis in Complement Component 6-Deficient Rats Is Associated with Reduced Complement C9 Deposition, P-Selectin Expression, and Cellular Infiltrate in Spinal Cords J. Immunol., May 1, 2002; 168(9): 4293 - 4300. [Abstract] [Full Text] [PDF]

				S. K. Singhrao, J. W. Neal, N. K. Rushmere, B. P. Morgan, and P. Gasque Spontaneous Classical Pathway Activation and Deficiency of Membrane Regulators Render Human Neurons Susceptible to Complement Lysis Am. J. Pathol., September 1, 2000; 157(3): 905 - 918. [Abstract] [Full Text] [PDF]

				A. Thomas, P. Gasque, D. Vaudry, B. Gonzalez, and M. Fontaine Expression of a complete and functional complement system by human neuronal cells in vitro Int. Immunol., July 1, 2000; 12(7): 1015 - 1023. [Abstract] [Full Text] [PDF]

				S. Junnikkala, T. S. Jokiranta, M. A. Friese, H. Jarva, P. F. Zipfel, and S. Meri Exceptional Resistance of Human H2 Glioblastoma Cells to Complement-Mediated Killing by Expression and Utilization of Factor H and Factor H-Like Protein 1 J. Immunol., June 1, 2000; 164(11): 6075 - 6081. [Abstract] [Full Text] [PDF]